Last $41.90 USD
Change Today -0.32 / -0.76%
Volume 1.1M
HCP On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 1:38 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

hcp inc (HCP) Snapshot

Open
$42.20
Previous Close
$42.22
Day High
$42.40
Day Low
$41.70
52 Week High
01/20/15 - $49.61
52 Week Low
03/20/14 - $36.00
Market Cap
19.3B
Average Volume 10 Days
3.3M
EPS TTM
$1.96
Shares Outstanding
460.8M
EX-Date
02/5/15
P/E TM
21.4x
Dividend
$2.26
Dividend Yield
5.26%
Current Stock Chart for HCP INC (HCP)

hcp inc (HCP) Related Businessweek News

No Related Businessweek News Found

hcp inc (HCP) Details

HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. It primarily invests in properties serving the healthcare industry including sectors of healthcare such as senior housing, life science, medical office, hospital and skilled nursing. The fund also invests in mezzanine loans and other debt instruments. It engages in acquisition, development, leasing, selling and managing of healthcare real estate and provides mortgage and other financing to healthcare providers. The fund benchmarks the performance of its portfolio against the S&P 500 Index, Berkshire Hathaway Index, and MSCI REIT Index. HCP, Inc. was formed in 1985 and is based in Irvine, California with additional office in Nashville and San Francisco.

170 Employees
Last Reported Date: 02/10/15
Founded in 1985

hcp inc (HCP) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $197.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $500.0K
Chief Investment Officer and Executive Vice P...
Total Annual Compensation: $500.0K
Chief Administrative Officer, Executive Vice ...
Total Annual Compensation: $500.0K
Executive Vice President of Medical Office Pr...
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2013.

hcp inc (HCP) Key Developments

Springhouse Of Silver Spring Up For Sale

Springhouse of Silver Spring will close this June because of the pending sale of the assisted-living apartment building, according to residents and a notice circulated by management this week. The notice, dated February 25, 2015 says that the landowner, HCP, Inc. (NYSE:HCP), is putting the property up for sale and that potential buyers might not continue to operate the property as a senior-living facility.

HCP, Inc. Adopts Amendments to Bylaws

On February 8, 2015, the board of directors of HCP, Inc. adopted amendments to the company's bylaws to implement proxy access (allowing eligible stockholders to include their own nominees for director in the company's proxy materials along with the Board-nominated candidates) and to make certain other conforming and technical changes. The proxy access process will first be available to stockholders in connection with the company's 2016 annual meeting of stockholders. The maximum number of stockholder nominees permitted under the proxy access provisions of the Bylaws is equal to 20% of the directors in office as of the last day a notice of nomination may be timely received. If the 20% calculation does not result in a whole number, the maximum number of stockholder nominees is the closest whole number below 20%. If one or more vacancies occurs for any reason after the nomination deadline and the Board decides to reduce the size of the Board in connection therewith, the 20% calculation will be applied to the reduced size of the Board, with the potential result that a stockholder nominee may be disqualified. Stockholder-nominated candidates whose nomination is withdrawn or whom the Board determines to include in the company's proxy materials as Board-nominated candidates will be counted against the 20% maximum. In addition, any director in office as of the nomination deadline who was included in the company's proxy materials as a stockholder nominee for either of the two preceding annual meetings and whom the Board decides to renominate for election to the Board also will be counted against the 20% maximum. Notice of a nomination pursuant to the proxy access provisions of the Bylaws must be received no earlier than 150 days and no later than 120 days before the anniversary of the date that the company distributed its proxy statement for the previous year's annual meeting of stockholders. If a group of stockholders is making the nomination, such notice must designate one member of the group for purposes of receiving communications, notices and inquiries from the company and otherwise authorize such member to act on behalf of each other member of the group with respect to the nomination. Each nominating stockholder must provide a list of its proposed nominees in rank order. If the number of stockholder nominees under the proxy access provisions of the Bylaws exceeds the 20% maximum, the high ranking qualified individual from the list proposed by each nominating stockholder, beginning with the nominating stockholder with the large qualifying ownership and proceeding through the list of nominating stockholders in descending order of qualifying ownership, will be selected for inclusion in the company's proxy materials until the maximum number is reached. Each stockholder seeking to include a director nominee in the company's proxy materials is required to provide certain information, including proof of qualifying stock ownership as of the date of the submission and the record date for the applicable annual meeting of stockholders, the stockholder's notice on Schedule 14N as filed with the Securities and Exchange Commission, and the information required by the advance notice provision of the Bylaws relating to nomination of directors (including the consent of each stockholder nominee to being named in the proxy statement and serving as a director, if elected). Nominating stockholders are also required to make certain representations and agreements regarding their intent to maintain qualifying ownership through the meeting date, intentions with respect to maintaining qualifying ownership for one year after the meeting date, lack of intent to effect a change of control, only nominating the person(s) nominated pursuant to the proxy access provisions of the Bylaws, only participating in the solicitation of their nominee or Board nominees, only distributing the company's form of proxy, complying with solicitation rules, providing accurate information, and assuming liabilities related to and indemnifying the company against losses arising out of the nomination. The company may also require each stockholder nominee to provide any additional information that may be reasonably requested to determine if such nominee is independent, that could be material to a reasonable stockholder's understanding of the nominee's independence or that may reasonably be required to determine the eligibility of such nominee to serve as a director of the company.

HCP, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Full Year 2015

HCP, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported total revenues of $603,528,000 against $530,297,000 a year ago. Income from continuing operations was $199,630,000 against $238,150,000 a year ago. Net income attributable to the company was $196,583,000 against $293,095,000 a year ago. Basic and diluted earnings per common share from continuing operations were $0.43 against $0.51 a year ago. FFO as adjusted and FAD per share increased year-over-year by 4% to $0.79 and 8% to $0.66, respectively; and FFO per share and EPS were $0.70 and $0.43, respectively. For the year, the company reported total revenues of $2,266,279,000 against $2,099,878,000 a year ago. Income from continuing operations was $906,845,000 against $910,633,000 a year ago. Net income attributable to the company was $922,233,000 against $970,837,000 a year ago. Basic and diluted earnings per common share from continuing operations were $1.94 against $1.97 a year ago. Net cash provided by operating activities was $1,248,621,000 against $1,148,987,000 a year ago. FFO as adjusted per share increased to $3.04; FAD per share increased to $2.57; and FFO per share and EPS were $3.00 and $2.00, respectively. For the full year 2015, the company not including the impact of future acquisitions or dispositions, for FFO per share of $3.14-$3.20, representing a growth rate of 6%; FFO as adjusted per share of $3.15-$3.21, representing a growth rate of 5%; FAD per share of $2.73-$2.79, representing a growth rate of 7%, and EPS of $1.98-$2.04. Year-over-year growth rates are based on the mid-point of 2015 estimates over their comparable 2014 amounts. Full year guidance for cash NOI SPP growth of 2.75%-3.75%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HCP:US $41.90 USD -0.32

HCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Brookdale Senior Living Inc $37.81 USD -0.14
Hammerson PLC 680.00 GBp -2.50
Health Care REIT Inc $76.87 USD -0.70
British Land Co PLC/The 848.50 GBp -1.50
Ventas Inc $73.21 USD -1.32
View Industry Companies
 

Industry Analysis

HCP

Industry Average

Valuation HCP Industry Range
No financial data is available for HCP.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HCP INC, please visit www.hcpi.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.